WuXi Biologics Secures FDA PLI Approval for Five Facilities, First for Commercial PFS Line

WuXi Biologics China

WuXi Biologics' pre-filled syringes (PFS) commercial production line passed its first FDA inspection, paving the way for global delivery of high-quality PFS solutions to clients worldwideReinforces WuXi Biologics' strong track record of a 100% success rate passing PLIs across our facilitiesView original content:https://www.prnewswire.co.uk/news-releases/wuxi-biologics-secures-fda-pli-approval-for-five-facilities-first-for-commercial-pfs-line-302510626.html